Otsuka America Pharmaceutical, Inc
Otsuka Pharmaceutical Co., Ltd. is a global healthcare company with the corporate philosophy: “Otsuka–people creating new products for better health worldwide.” Otsuka researches, develops, manufactures, and markets innovative products, with a focus on pharmaceutical products to meet unmet medical needs and nutraceutical products for the maintenance of everyday health. At our core is perseverance, a fierce determination to overcome any obstacle regardless of setbacks, on behalf of patients and their loved ones. We place greater value on what we can achieve together than on what we can do alone because the needs of those we serve always come first. We will not be bound by doing what’s been done before. Instead, we free ourselves from preconceived notions to discover solutions that advance patient care. Our mission is clear: Otsuka-people, creating new products for better health worldwide.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Globally (various continents)
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
There are two Otsuka pharmaceutical industry compa...
Otsuka America Pharmaceutical, Inc. (OAPI) successfully commercializes Otsuka-discovered and in-licensed products in North America.
Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) clinically develops and registers innovative healthcare products on a global basis.
We are doing everything in our power to live up to our mission in three important categories.
Our driving philosophy at Otsuka is to serve those with unmet medical needs, and that couldn’t be more true than in our dedication to the central nervous system (CNS) space. In our 30 years of experience working in this therapeutic area, we continue to innovate and defy limitation by taking risks to overcome the complexities of treating mental health. We respect the value within every mind and are committed to making a difference in the lives of patients living with schizophrenia, major depressive disorder, bipolar disorder, and other CNS conditions.
When Otsuka saw a need for clinical expertise and research in the nephrology space, we decided to lead the way. For more than 20 years, we have been bringing our research and expertise to this therapeutic area. We have focused on developing novel drugs in areas of unmet need, such as autosomal dominant polycystic kidney disease and hyponatremia, that have changed the treatment landscape. Our long-term perseverance has led to major breakthroughs, giving patients renewed hope and clinicians more options than ever before.
Digital technology has not only changed the world we live in, but it is also changing the face of healthcare. Otsuka is at the forefront of this transformative juncture in medicine, creating novel solutions that help address the challenges of those living with serious mental illness. We believe our investment and leadership in this therapeutic area will revolutionize patient care as we know it. Patients will be able to engage and communicate with their care teams in new ways, and clinicians will have data-driven insights that may help inform treatment decisions.
Our Family of Companies
Our parent, Otsuka America, Inc (OAI), consists of multiple companies committed to offering innovative products that go beyond healthcare to improve the health and well-being of patients. Otsuka America Pharmaceutical, Inc. (OAPI) and Otsuka Pharmaceutical Development, Inc. (OPDC) belong to a distinguished family of US affiliates.
Research and Development
When it comes to research at Otsuka, our mission—creating new products for better health worldwide—is at the center of everything we do. That’s why we are dedicated to finding unconventional solutions for complex, underserved medical needs, whether we are developing new compounds at one of our research facilities in the United States, Europe, Japan, and beyond; or collaborating with another company to develop innovative therapies.
We are committed to developing new treatments in neuroscience and nephrology, where the needs of patients are underserved.
We persevere, no matter how long it takes, while putting the health and safety of patients first.
We leverage our global resources to develop unique projects that defy limitation, so that others can too.